EUVIMEDEUVIMED entdecken
Open Access

Metabolic engineering to facilitate anti-tumor immunity

Tanya Schild, Patrick Wallisch, Yixuan Zhao, Ya-Ting Wang, Lyric Haughton, Rachel Chirayil, Kaitlyn Pierpont, Kevin Chen, Sara Nunes-Violante, Justin Cross, Elisa de Stanchina, Craig B Thompson und 3 weitere

Cancer Cell · 2025

DOI: 10.1016/j.ccell.2025.02.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2025. Verfasst von Tanya Schild und 14 weiteren Autor:innen. Beteiligte Einrichtung: Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, N…. Hauptthemen laut MEDLINE: Fructose, Metabolic Engineering, Glucose Transporter Type 5, Neoplasms. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FructoseMetabolic EngineeringGlucose Transporter Type 5NeoplasmsAnimalsHumansMiceTumor MicroenvironmentCD8-Positive T-LymphocytesMacrophagesXenograft Model Antitumor AssaysCell Line, TumorReceptors, Chimeric AntigenGlucoseMice, Inbred C57BLImmunotherapy, Adoptive

Stichwörter der Autor:innen

CAR-Tfructosemacrophagesmetabolic engineeringslc2a5t cell

Substanzen

FructoseGlucose Transporter Type 5Receptors, Chimeric AntigenGlucose

Autor:innen und Institutionen

  • Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Pharmacology Program, Weill Cornell Graduate School of Medical Sciences, Cornell University, New York, NY 10065, USA.
  • Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Gerstner Sloan Kettering School for Biomedical…
  • Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Anti-tumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Metabolism Core, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health
  • Cycle for Survival
  • National Institute of General Medical Sciences
  • Memorial Sloan-Kettering Cancer Center
  • National Cancer Institute

Zitieren

APA

Schild, T., Wallisch, P., Zhao, Y., Wang, Y. T., Haughton, L., Chirayil, R., Pierpont, K., Chen, K., Nunes-Violante, S., Cross, J., de Stanchina, E., Thompson, C. B., Scheinberg, D. A., Perry, J. S. A., & Keshari, K. R. (2025). Metabolic engineering to facilitate anti-tumor immunity. Cancer Cell. https://doi.org/10.1016/j.ccell.2025.02.004

Vancouver

Schild T, Wallisch P, Zhao Y, Wang YT, Haughton L, Chirayil R, et al. Metabolic engineering to facilitate anti-tumor immunity. Cancer Cell. 2025. doi:10.1016/j.ccell.2025.02.004

BibTeX
@article{Schild2025,
  author = {Schild, Tanya and Wallisch, Patrick and Zhao, Yixuan and Wang, Ya-Ting and Haughton, Lyric and Chirayil, Rachel and Pierpont, Kaitlyn and Chen, Kevin and Nunes-Violante, Sara and Cross, Justin and de Stanchina, Elisa and Thompson, Craig B and Scheinberg, David A and Perry, Justin S A and Keshari, Kayvan R},
  title = {Metabolic engineering to facilitate anti-tumor immunity},
  journal = {Cancer Cell},
  year = {2025},
  doi = {10.1016/j.ccell.2025.02.004}
}
Kostenlos starten →